Elias U.S.A., Inc.: FDA filings under this applicant name
FDA lists 54 510(k) clearances under the applicant name “Elias U.S.A., Inc.” (first 1992, latest 1997), across 21 product codes in 3 review panels. Median 510(k) review time under this name: 118 days. Related companies, subsidiaries and acquired businesses that file under other applicant names are counted on their own pages, not here.
510(k) clearances per year
| Year | Clearances | Median review days |
|---|---|---|
| 2012 | 0 | — |
| 2013 | 0 | — |
| 2014 | 0 | — |
| 2015 | 0 | — |
| 2016 | 0 | — |
| 2017 | 0 | — |
| 2018 | 0 | — |
| 2019 | 0 | — |
| 2020 | 0 | — |
| 2021 | 0 | — |
| 2022 | 0 | — |
| 2023 | 0 | — |
| 2024 | 0 | — |
| 2025 | 0 | — |
| 2026 | 0 | — |
Top product codes
| Product code | Device | Submissions | 510(k) clearances |
|---|---|---|---|
| LJM | Antinuclear Antibody (Enzyme-Labeled), Antigen, Controls | 16 | 16 |
| MID | System, Test, Anticardiolipin Immunological | 7 | 7 |
| JZO | System, Test, Thyroid Autoantibody | 5 | 5 |
| LLL | Extractable Antinuclear Antibody, Antigen And Control | 4 | 4 |
| LKJ | Antinuclear Antibody, Antigen, Control | 3 | 3 |
| DBM | Antimitochondrial Antibody, Indirect Immunofluorescent, Antigen, Control | 2 | 2 |
| LRM | Anti-Dna Antibody (Enzyme-Labeled), Antigen, Control | 2 | 2 |
| MOB | Test System, Antineutrophil Cytoplasmic Antibodies (Anca) | 2 | 2 |
| CGR | Radioimmunoassay, Cortisol | 1 | 1 |
| DBJ | Antiparietal Antibody, Indirect Immunofluorescent, Antigen, Control | 1 | 1 |
Plus 11 more product codes.
Review panels
- Immunology (49)
- Clinical Chemistry (4)
- Microbiology (1)
Most recent Elias U.S.A., Inc. 510(k) clearances
| 510(k) | Device | Product code | Decision date | Review days |
|---|---|---|---|---|
| K964385 | ELIAS ANA-HEP-2 | LJM | 1997-03-06 | 122 |
| K963291 | VARELISA ANA (4) PROFILE | LJM | 1996-09-30 | 40 |
| K953873 | VARELISA HELICOBACTER PYLORI ANTIBODIES | LYR | 1996-08-30 | 379 |
| K953587 | VARELISA MPO-ANCA | MOB | 1996-01-26 | 178 |
| K953586 | VARELISA PR3-ANCA | MOB | 1996-01-26 | 178 |
| K951187 | VARELISA CARDIOLIPIN ABS SCREEN | MID | 1995-10-02 | 200 |
| K951207 | VARELISA HISTONE ANTIBODIES | LJM | 1995-04-17 | 31 |
| K951206 | VARELISA PARIETAL CELL ANTIBODIES | MLE | 1995-04-17 | 31 |
| K951205 | VARELISA ANA PROFILE | LJM | 1995-04-17 | 31 |
| K951186 | VARELISA ANA-4 SCREEN | LJM | 1995-04-17 | 32 |
44 earlier clearances. See the full list in Caduvo.
Recalls
FDA recall records list no recalls under a recalling firm named Elias U.S.A., Inc..
Recalling firms are matched to this applicant name by name only (same normalization), so related entities that recall under another name are not counted. A recall count says nothing about how safe one company's devices are compared with another's.
Frequently asked questions
How many FDA 510(k) clearances are listed under Elias U.S.A., Inc.?
FDA lists 54 510(k) clearances under the applicant name “Elias U.S.A., Inc.” (first 1992, latest 1997), across 21 product codes in 3 review panels. Filings under other applicant names, such as subsidiaries, are not included.
How long has FDA taken to clear 510(k)s filed by Elias U.S.A., Inc.?
The median time from FDA receipt to decision across 510(k)s cleared under the name Elias U.S.A., Inc. is 118 days.
Which FDA product codes appear under Elias U.S.A., Inc.?
The most frequent FDA product codes under this applicant name are LJM (Antinuclear Antibody (Enzyme-Labeled), Antigen, Controls, 16); MID (System, Test, Anticardiolipin Immunological, 7); JZO (System, Test, Thyroid Autoantibody, 5).
Next steps
- See all 54 Elias U.S.A., Inc. clearances with predicates and recalls
- Run predicate analysis for product code LJM, Elias U.S.A., Inc.'s most frequent
Compiled by Caduvo from public U.S. government records. Counts cover filings under the applicant name shown on this page only. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA or any other agency, or by the companies named. Not regulatory advice. Report an error in this data. Data and corrections policy.